Solk Payton, Song Jing, Reading Jean, Starikovsky Julia, Cullather Erin, Wang Shirlene, Hasanaj Kristina, Morelli Whitney A, Spring Bonnie, Cella David, Penedo Frank, Ackermann Ron, Courneya Kerry S, Siddique Juned, Frey Julia, Phillips Siobhan M
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, 680 N. Lake Shore Drive, Chicago, IL 60611, United States.
Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin, 9200 W. Wisconsin Ave., Milwaukee, WI 53226, United States.
Transl Behav Med. 2025 Jan 16;15(1). doi: 10.1093/tbm/ibaf033.
Most breast cancer survivors (BCS) are insufficiently active. mHealth moderate-to-vigorous physical activity (MVPA) interventions for BCS are highly scalable, but the feasibility and acceptability of specific intervention components are unknown.
The purpose of this study is to examine the feasibility and acceptability of the Fit2Thrive MVPA promotion intervention components.
Using Multiphase Optimization Strategy methodology, inactive BCS [n = 269; Mage = 52.5; (SD ± 9.9)] received a core intervention (Fitbit + Fit2Thrive smartphone app) and were randomly assigned to receive zero to five components for 12 weeks: (i) support calls; (ii) deluxe app; (iii) text messages, (iv) online gym; and (v) Buddy. Feasibility was measured through study accrual, retention, and adherence rates. Acceptability was measured via post-program evaluations.
Enrollment rates were high; 419 BCS expressed interest in the study, 348 (83%) passed screening, and 269 (77%) were randomized; 98% (n = 264) received the intervention. Retention was 94% at 12 weeks. Fitbits were worn on 93% of study days. Most reported using the app ≥5 days/week (67%), enjoyed using the Fitbit (79%), and were satisfied with their study experience (88%) and the Fit2Thrive app design (79%). Component adherence rates and acceptability varied by intervention component. Component-specific effects on MVPA goal adherence and overall acceptability ratings were significant for telephone support calls.
Findings indicate Fit2Thrive's feasibility and acceptability were high overall but may vary by component. Future work should refine and test components to maximize participant engagement, efficacy, and scalability.
The Clinical Trials Registration NCT03131440.
大多数乳腺癌幸存者的活动量不足。针对乳腺癌幸存者的移动健康中等到剧烈身体活动(MVPA)干预措施具有高度可扩展性,但具体干预组件的可行性和可接受性尚不清楚。
本研究旨在检验Fit2Thrive MVPA促进干预组件的可行性和可接受性。
采用多阶段优化策略方法,不活跃的乳腺癌幸存者[n = 269;年龄中位数 = 52.5;(标准差±9.9)]接受核心干预(Fitbit + Fit2Thrive智能手机应用程序),并被随机分配接受0至5个组件,为期12周:(i)支持电话;(ii)豪华应用程序;(iii)短信;(iv)在线健身房;(v)伙伴。通过研究招募率、保留率和依从率来衡量可行性。通过项目后评估来衡量可接受性。
招募率很高;419名乳腺癌幸存者表示对该研究感兴趣,348名(83%)通过筛选,269名(77%)被随机分组;98%(n = 264)接受了干预。12周时的保留率为94%。在93%的研究日佩戴了Fitbit。大多数人报告每周至少使用应用程序5天(67%),喜欢使用Fitbit(79%),对他们的研究体验(88%)和Fit2Thrive应用程序设计(79%)感到满意。组件依从率和可接受性因干预组件而异。电话支持对MVPA目标依从性和总体可接受性评分的特定组件效应显著。
研究结果表明,Fit2Thrive的总体可行性和可接受性较高,但可能因组件而异。未来的工作应优化和测试组件,以最大限度地提高参与者的参与度、疗效和可扩展性。
临床试验注册号NCT03131440。